TerrAscend (TSNDF) Equity Average (2021 - 2026)
TerrAscend (TSNDF) reported Equity Average of $95.0 million for Q1 2026, down 44.44% year-over-year from $171.0 million in Q1 2025, and down 2.34% quarter-over-quarter from $97.3 million in Q4 2025.
TerrAscend (TSNDF) Equity Average (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Equity Average data on file, last reported at $95.0 million in Q1 2026.
- Equity Average for Q1 2026 came in at $95.0 million, down 44.44% year-over-year; the trailing twelve-month figure through Mar 2026 was $95.0 million (down 44.44% YoY), and the FY2025 annual result was $137.9 million, down 33.94% from the prior year.
- Equity Average slipped to $95.0 million in Q1 2026 per TSNDF's latest filing, from $97.3 million in the prior quarter.
- Over five years, Equity Average peaked at $552.6 million in Q2 2022 and troughed at $95.0 million in Q1 2026.
- A 5-year average of $253.2 million and a median of $236.4 million in 2024 frame the typical range for Equity Average.
- The sharpest annual moves came in 2022 and 2025: Equity Average jumped 344.05% in 2022, then tumbled 50.64% in 2025.
- A 5-year view of Equity Average shows it stood at $300.0 million in 2022, then retreated by 12.41% to $262.8 million in 2023, then decreased by 26.94% to $192.0 million in 2024, then plunged by 49.34% to $97.3 million in 2025, then retreated by 2.34% to $95.0 million in 2026.
- Business Quant data shows TSNDF's Equity Average at $95.0 million in Q1 2026, $97.3 million in Q4 2025, and $106.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.07 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 3.32 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 6.50 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 409.63 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 3.33 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.52 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.79 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 493.55 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.15 Bn |
| 10 | TerrAscend | - | - | 34.60 Mn | 94.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 94.98 Mn |
| Dec 31, 2025 | 97.25 Mn |
| Sep 30, 2025 | 106.93 Mn |
| Jun 30, 2025 | 141.75 Mn |
| Mar 31, 2025 | 170.96 Mn |
| Dec 31, 2024 | 191.97 Mn |
| Sep 30, 2024 | 216.63 Mn |
| Jun 30, 2024 | 229.13 Mn |
| Mar 31, 2024 | 236.42 Mn |
| Dec 31, 2023 | 262.76 Mn |
| Sep 30, 2023 | 289.36 Mn |
| Jun 30, 2023 | 296.62 Mn |
| Mar 31, 2023 | 310.24 Mn |
| Dec 31, 2022 | 300.00 Mn |
| Sep 30, 2022 | 429.40 Mn |
| Jun 30, 2022 | 552.61 Mn |
| Mar 31, 2022 | 377.10 Mn |
| Dec 31, 2021 | 220.85 Mn |
| Sep 30, 2021 | 207.74 Mn |
| Jun 30, 2021 | 192.95 Mn |